HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaodong Xu Selected Research

Chronic Hepatitis B

1/2017Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
6/2013Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.
9/2010Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaodong Xu Research Topics

Disease

36Neoplasms (Cancer)
05/2022 - 01/2013
28Infections
08/2022 - 04/2009
11Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 08/2016
8Hepatocellular Carcinoma (Hepatoma)
05/2022 - 01/2013
7Neoplasm Metastasis (Metastasis)
01/2022 - 01/2015
5Stomach Neoplasms (Stomach Cancer)
01/2019 - 02/2014
5Hemolysis
11/2015 - 06/2014
4Breast Neoplasms (Breast Cancer)
10/2020 - 01/2019
4Colorectal Neoplasms (Colorectal Cancer)
10/2019 - 11/2013
4Chronic Hepatitis C
06/2014 - 03/2011
3Fibrosis (Cirrhosis)
07/2022 - 06/2013
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2021
3Melanoma (Melanoma, Malignant)
01/2019 - 11/2017
3Chronic Hepatitis B
01/2017 - 09/2010
3Diarrhea
04/2013 - 04/2009
2Carcinogenesis
05/2022 - 02/2021
2Acquired Immunodeficiency Syndrome (AIDS)
03/2022 - 07/2017
2Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/2022 - 01/2019
2Wounds and Injuries (Trauma)
01/2022 - 03/2018
2Cholangiocarcinoma
01/2022 - 08/2017
2Necrosis
04/2021 - 06/2016
2Septic Shock (Toxic Shock Syndrome)
01/2021 - 01/2021
2Proteinuria
01/2021 - 08/2017
2Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2021 - 07/2014
2Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
07/2019 - 01/2019
2Inflammation (Inflammations)
05/2018 - 01/2015
2Urinary Bladder Neoplasms (Bladder Cancer)
11/2015 - 01/2015
2Insulin Resistance
01/2015 - 07/2014
2Virus Diseases (Viral Diseases)
07/2014 - 08/2012
2Coinfection
07/2014 - 01/2013
2Viremia
11/2011 - 01/2011
1Hemorrhage
08/2022
1Cardiomyopathies (Cardiomyopathy)
07/2022
1Multiple Myeloma
04/2022
1Mitochondrial Diseases (Mitochondrial Disease)
03/2022
1Membranous Glomerulonephritis (Membranous Nephropathy)
03/2022
1Tics (Tic)
02/2022
1Bacterial Infections (Bacterial Infection)
01/2022
1Flushing
01/2022

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
03/2022 - 01/2013
11Antiviral Agents (Antivirals)IBA
01/2017 - 04/2009
8CytokinesIBA
03/2022 - 05/2013
7Pharmaceutical PreparationsIBA
05/2022 - 03/2011
6Biological ProductsIBA
03/2022 - 07/2012
5Messenger RNA (mRNA)IBA
03/2022 - 07/2014
5Long Noncoding RNAIBA
01/2022 - 08/2017
5LipidsIBA
04/2021 - 01/2015
4Circular RNAIBA
04/2022 - 01/2020
4Peptides (Polypeptides)IBA
03/2022 - 01/2013
4MicroRNAs (MicroRNA)IBA
12/2021 - 01/2020
4Small Interfering RNA (siRNA)IBA
07/2019 - 03/2015
4SugarsIBA
06/2013 - 04/2009
4GlucosidasesIBA
06/2013 - 01/2011
3IronIBA
01/2022 - 01/2019
3Blood Glucose (Blood Sugar)IBA
01/2021 - 07/2014
3Interferon-gamma (Interferon, gamma)IBA
01/2020 - 09/2010
3LuciferasesIBA
01/2020 - 01/2019
3tocophersolanIBA
11/2015 - 08/2014
2Polysaccharides (Glycans)IBA
01/2022 - 12/2015
2Histones (Histone)IBA
01/2021 - 10/2020
2fisetinIBA
10/2020 - 01/2019
2SincalideFDA Link
10/2020 - 04/2017
2FlavonoidsIBA
10/2020 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 05/2018
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2020 - 01/2019
2RNA (Ribonucleic Acid)IBA
01/2020 - 06/2016
2Carrier Proteins (Binding Protein)IBA
12/2019 - 08/2017
2VaccinesIBA
10/2019 - 09/2014
2Versicans (Versican)IBA
07/2019 - 01/2019
2Interleukin-6 (Interleukin 6)IBA
07/2019 - 01/2019
2PolymersIBA
01/2019 - 03/2015
2Interleukin-18 (Interleukin 18)IBA
03/2018 - 12/2016
2Antineoplastic Agents (Antineoplastics)IBA
06/2016 - 01/2015
2Lactic Acid (Lactate)FDA LinkGeneric
11/2015 - 01/2015
2Lipid Bilayers (Lipid Bilayer)IBA
11/2015 - 08/2014
2AntioxidantsIBA
03/2015 - 01/2015
2LecithinsIBA
01/2015 - 06/2014
2AntibodiesIBA
07/2014 - 05/2013
2Imino SugarsIBA
06/2013 - 01/2011
2Interferon-alpha (Interferon Alfa)IBA
06/2013 - 09/2010
1Hemostatics (Antihemorrhagics)IBA
08/2022
1AlginatesIBA
08/2022
1ChitosanIBA
08/2022
1GadoliniumIBA
07/2022
1Amyloid (Amyloid Fibrils)IBA
05/2022
1Complement System Proteins (Complement)IBA
03/2022
1ElectrolytesIBA
03/2022
1Oxygen (Dioxygen)IBA
03/2022
1SaltsIBA
03/2022
1RNA Splice SitesIBA
02/2022
1SilverIBA
01/2022
1Aldehyde DehydrogenaseIBA
01/2022
1Competitive Endogenous RNAIBA
01/2022

Therapy/Procedure

13Therapeutics
05/2022 - 04/2009
3Laparotomy
01/2021 - 03/2014
2Treatment Delay
01/2021 - 01/2020
2Drug Therapy (Chemotherapy)
10/2020 - 10/2020
2Radiotherapy
01/2019 - 12/2018
2Nutritional Support (Artificial Feeding)
06/2018 - 03/2014
2Oral Administration
01/2017 - 01/2011